insights_auto
Why is INO down 2.10%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.40
arrow_downward
-2.10%(-0.030) 1D
$1.39
arrow_downward
-0.71% (-0.0100)bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
262.23M
Avg. vol.
19.34M
Volume
6.52M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.42
High
$1.48
Low
$1.37
Mkt. cap
262.23M
Avg. vol.
19.34M
Volume
6.52M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
Investing.com
·
20 minutes ago
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 hour ago
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
45 minutes ago
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com